Page 2 - Chocolate Touch News Today

Patients treated for a blocked artery in the leg were significantly more likely to have an open artery without further interventions at 12 months if they received the second-generation paclitaxel-coated balloon catheter known as the Chocolate Touch device compared with those receiving the commercially-available Lutonix drug-coated balloon catheter, according to a study presented at the American College of Cardiology's 71st Annual Scientific Session.

WASHINGTON — A new study supports the safety and effectiveness of the Chocolate Touch drug-coated balloon for the treatment of symptomatic peripheral arterial disease with lesions in superficial femoral and popliteal arteries.The second-generation Chocolate Touch DCB (TriReme Medical) met both noninferiority endpoints for safety and efficacy and was more effective than the first-generation

Going forward it will be important to understand which unique aspects of the novel stent give it an outcomes advantage.

The multiverse exists as the ACC offers a traditional in-person meeting spanning all of cardiology paired with what could be a lasting legacy of the pandemic, a robust, parallel virtual experience.

UPDATE ON CHOCOLATE TOUCH® US PIVOTAL STUDY Key Points: The clinical report with 12 months post-procedure analysis of the... | December 17, 2021

For Immediate Release Central Illinois Rural Teacher Corps grants announced (EFFINGHAM, Illinois) Southeastern...